Navigation Links
Moleculin Reports Positive Data From Controlled Study of Novel Topical Psoriasis Treatment
Date:9/30/2013

mpound safe for long-term, chronic use.

About Psoriasis

Psoriasis is a chronic autoimmune skin disease that occurs when the immune system mistakenly speeds up the growth cycle of skin cells. It affects up to 7.5 million Americans and can be difficult to treat because of side effects such as atrophy, or thinning of the skin, with long-term use.

Plaque psoriasis is the most common form of the disease in which people develop itchy skin spots, red patches, and a silvery white buildup of dead skin cells most often appearing on the scalp, lower back, knees, and elbows.

According to a patient survey conducted in the U.S. between 2001 and 2008 by the National Psoriasis Foundation, 33% of patients with mild disease and 60% of patients with moderate-to-severe psoriasis reported that their disease significantly affects their everyday life.

About Moleculin

Moleculin is a clinical-stage pharmaceutical company advancing a new therapeutic approach to inflammatory and proliferative skin diseases, including psoriasis, atopic dermatitis, actinic keratosis, and several skin cancers. The Company's topical compounds are based on the direct inhibition of activated STAT3 (p-STAT3), an important target in the fight against chronic skin diseases. MOL4249, the Company's lead product candidate, is currently being studied in psoriasis. Early clinical studies with this p-STAT3 inhibitor suggest improved efficacy and tolerability for the treatment of mild-to-moderate psoriasis. For more information, visit moleculin.com.


'/>"/>
SOURCE Moleculin, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
2. Allied Healthcare Products Reports Loss On Sales Decline
3. TPI Reports Fiscal Year 2013 Financial Results
4. Isis Reports Phase 2 Data on ISIS-APOCIII Rx Showing Substantial Reductions of Triglycerides and Apoc-III in Patients with Familial Chylomicronemia
5. Omeros Reports Initiation of Phase 2 Clinical Trial with OMS824
6. Isis Reports Follow-Up Data From ISIS-SMN Rx Phase 1 Study In Children With Spinal Muscular Atrophy
7. InspireMD Reports Fourth Quarter and Fiscal Year 2013 Results
8. Apollo Medical Holdings Reports Record Fiscal 2014 Second Quarter Results
9. Cyberonics Reports Inducement Equity Award Under NASDAQ Listing Rule 5635(c)(4)
10. Genocea Reports Positive Initial Phase 1/2a Results for GEN-003, its Pioneering Therapeutic Vaccine Candidate for the Treatment of Herpes Simplex Virus-2 (HSV-2), at ICAAC 2013
11. Omeros Reports Additional Positive Results from OMS824 Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2, 2015  Champions Oncology, Inc. (OTC-PINK: CSBR), a ... and services to personalize the development and use of ... the $2 million convertible promissory notes with two of ... Dr. David Sidransky , chairman of ... from the confidence and commitment of our two senior ...
(Date:3/2/2015)... HOUSTON, TX , March 2, 2015 ... (TSX-V: EPI) today reported financial results for the first ... unless specified otherwise, are expressed in Canadian dollars and ... Summary Results ESSA recorded ... share) for the three months ended December 31, 2014 ...
(Date:3/2/2015)... , March 2, 2015 Attorney Advertising ... potential claims on behalf of purchasers of the ... the "Company") (NasdaqGM: VTAE -News).  Such investors are ... his investor relations coordinator Eitan Kimelman ... The investigation concerns whether Vitae Pharmaceuticals and certain ...
Breaking Medicine Technology:Champions Oncology Extends Convertible Debt Financing 2Champions Oncology Extends Convertible Debt Financing 3ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 2ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 3ESSA Pharma Inc. Reports First Quarter 2015 Financial Results 4SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vitae Pharmaceuticals, Inc. 2
(Date:3/2/2015)... March 02, 2015 GBCHealth, a ... catalyzing private sector activities and investments in global ... elected four new members to serve on the ... Paul Farmer, Chief Strategist and Co-founder of Partners ... University; Dr. Huma Abbasi, General Manager of Global ...
(Date:3/2/2015)... Angeles, CA (PRWEB) March 02, 2015 ... Buffett tickets at the Hollywood Bowl . This popular ... add customer appreciation promo code JIMMY-BUFFETT-2015 for added savings. ... because their favorite performer will be headlining at the ... This concert will be on Thursday, October 22nd and ...
(Date:3/2/2015)... March 02, 2015 While many hospitals ... VI of the Civil Rights Act, the unique needs ... loss are bringing light to the value of video ... that nearly 1 in 20 U.S. children have LEP—a ... in some major cities.(1) Stratus Video Interpreting ...
(Date:3/2/2015)... 2015 ZoomCare announced today the ... healthcare. Zoom will expand its Portland on-demand neighborhood ... advanced care studios delivering urgent care, primary care, ... care and outpatient surgery. With its new neighborhood ... all healthcare needs outside of hospitalization. , “2015 ...
(Date:3/2/2015)... 2015 After a rigorous evaluation process ... pricing and long-term strategy, Blood Centers of America (BCA) ... for member centers’ testing needs. , BCA, which comprises ... than 30 percent of the U.S. blood supply, made ... is committed to drive cost savings to members,” said ...
Breaking Medicine News(10 mins):Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 4Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 5Health News:Cheap Jimmy Buffett Tickets Hollywood Bowl: Ticket Down Slashes Prices on Jimmy Buffett Tickets at the Hollywood Bowl in Los Angeles/Hollywood, CA 2Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 2Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 4Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 2Health News:ZoomCare Announces 28-Location, On-Demand Neighborhood Health Campus 3Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3
... epinephrine causes changes in prostate and breast cancer cells that ... study. // ,"This data implies that emotional stress ... reduce the effectiveness of cancer treatments," said George Kulik, a ... ,Levels of epinephrine, which is produced by the adrenal ...
... with findings that dispel the halo around dieting regimes. Not ... they also stand higher risks of developing diabetes, heart attacks ... in the journal American Psychologist, based their research on thousands ... more than 30 studies on the subject. , ...
... Health Organization has reiterated the earlier warning about the ... consumption salt. The report has impressed upon governments world-wide ... sodium to 2,000 milligrams per day, 50% less than ... has been pressurizing the U.S. Food and Drug Administration ...
... to be flooding their body with dietary supplements, without ... $5.8 billion //is spent by Americans annually on dietary ... diseases at bay and extend life. ... claims of enhancing cardiovascular health. Ginkgo biloba, another dietary ...
... to 301 in 2006, the maternal mortality ratio (MMR) that ... falling in India, albeit gradually. ,As India observes ... MMR rate, the number of mothers dying per 100,000 live ... of the White Ribbon Alliance (WRA), an international body that ...
... with Parkinson's disease are less likely to smoke ... family members who do not have the disease//, ... consuming caffeine and taking non-steroidal anti-inflammatory (NSAID) medications ... reported to protect individuals from developing Parkinson's disease, ...
Cached Medicine News:Health News:Dieting Fads -Flab Revisited 2Health News:Ray of Hope for Women on Motherhood Day 2Health News:Smoking and Caffeine Inversely Associated With Parkinson's Disease 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: